data_2ajn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ajn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.102 0.477 . . . . 5.9 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.93 83.56 1.61 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.579 -1.409 . . . . 3.27 109.579 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -108.84 162.48 14.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.53 -0.983 . . . . 4.48 110.462 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -105.43 -25.49 12.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.524 -0.735 . . . . 4.22 110.505 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -60.71 -41.22 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 2.64 110.258 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.5 tt -58.6 -40.72 84.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.301 -0.874 . . . . 3.08 108.936 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.307 -0.627 . . . . 2.09 109.307 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -31.01 61.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 1.73 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.9 mm -50.35 -28.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.523 -0.736 . . . . 2.46 109.645 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CG ' ' N ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.26 -43.3 70.83 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.283 -0.636 . . . . 2.58 109.283 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.483 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 6.8 t -69.74 -38.57 76.87 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.98 -0.748 . . . . 1.44 108.98 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.91 -41.19 97.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.176 -0.676 . . . . 2.63 109.176 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -68.69 -35.11 76.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.837 -0.539 . . . . 2.59 109.896 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -36.05 66.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 3.94 109.895 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.847 -0.797 . . . . 2.55 108.847 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mt -64.49 -35.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.209 -0.663 . . . . 2.01 109.209 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -44.38 90.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.853 -0.529 . . . . 2.17 109.999 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 -52.91 -49.53 65.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.641 -0.662 . . . . 4.66 110.153 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.17 -45.45 49.27 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.263 -1.535 . . . . 1.09 109.263 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.0 tp -57.36 -44.29 84.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.663 -0.904 . . . . 2.07 110.258 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.25 81.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.761 -0.587 . . . . 3.17 110.413 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -39.53 90.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.568 -0.707 . . . . 2.74 110.491 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 20' ' ' LEU . 40.9 mt -60.65 -45.96 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.52 -0.737 . . . . 2.55 109.857 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.8 t -76.76 -32.42 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.683 -0.636 . . . . 2.11 109.759 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.21 -33.19 71.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.654 . . . . 2.52 110.294 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.78 -46.87 4.4 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.958 -1.257 . . . . 1.75 109.958 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.83 152.27 48.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -1.045 . . . . 6.64 110.677 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.127 0 CA-C-O 118.769 -0.634 . . . . 4.75 110.738 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.102 0.477 . . . . 5.48 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.93 83.56 1.61 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.579 -1.409 . . . . 3.05 109.579 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -108.84 162.48 14.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.53 -0.983 . . . . 3.76 110.462 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -105.43 -25.49 12.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.524 -0.735 . . . . 3.97 110.505 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 6' ' ' LEU . 34.0 m -60.71 -41.22 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 2.11 110.258 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HG23 ' A' ' 5' ' ' VAL . 3.5 tt -58.6 -40.72 84.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.301 -0.874 . . . . 2.58 108.936 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.307 -0.627 . . . . 2.09 109.307 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -31.01 61.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 1.24 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.9 mm -50.35 -28.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.523 -0.736 . . . . 1.86 109.645 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CG ' ' N ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.26 -43.3 70.83 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.283 -0.636 . . . . 1.85 109.283 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.483 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 6.8 t -69.74 -38.57 76.87 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.98 -0.748 . . . . 1.17 108.98 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 12' ' ' LEU . 1.8 mt -61.91 -41.19 97.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.176 -0.676 . . . . 2.09 109.176 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -68.69 -35.11 76.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.837 -0.539 . . . . 1.95 109.896 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -36.05 66.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 3.49 109.895 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.847 -0.797 . . . . 2.48 108.847 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mt -64.49 -35.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.209 -0.663 . . . . 1.5 109.209 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -44.38 90.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.853 -0.529 . . . . 1.74 109.999 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 -52.91 -49.53 65.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.641 -0.662 . . . . 4.07 110.153 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.17 -45.45 49.27 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.263 -1.535 . . . . 0.89 109.263 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.0 tp -57.36 -44.29 84.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.663 -0.904 . . . . 1.62 110.258 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.25 81.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.761 -0.587 . . . . 2.8 110.413 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -39.53 90.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.568 -0.707 . . . . 2.21 110.491 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 20' ' ' LEU . 40.9 mt -60.65 -45.96 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.52 -0.737 . . . . 2.02 109.857 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.8 t -76.76 -32.42 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.683 -0.636 . . . . 1.69 109.759 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.21 -33.19 71.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.654 . . . . 2.07 110.294 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.78 -46.87 4.4 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.958 -1.257 . . . . 1.75 109.958 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -127.83 152.27 48.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -1.045 . . . . 5.71 110.677 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' TRP . . . . . . . . 0 N--CA 1.502 2.127 0 CA-C-O 118.769 -0.634 . . . . 4.75 110.738 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.102 0.477 . . . . 5.48 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.93 83.56 1.61 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.579 -1.409 . . . . 3.05 109.579 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -108.84 162.48 14.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.53 -0.983 . . . . 3.76 110.462 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -105.43 -25.49 12.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.524 -0.735 . . . . 3.97 110.505 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 6' ' ' LEU . 34.0 m -60.71 -41.22 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.273 -0.892 . . . . 2.11 110.258 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HG23 ' A' ' 5' ' ' VAL . 3.5 tt -58.6 -40.72 84.02 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.301 -0.874 . . . . 2.58 108.936 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.13 -35.23 79.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.307 -0.627 . . . . 2.09 109.307 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.76 -31.01 61.66 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 1.24 110.776 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.9 mm -50.35 -28.57 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 121.523 -0.736 . . . . 1.86 109.645 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.483 ' CG ' ' N ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -54.26 -43.3 70.83 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.283 -0.636 . . . . 1.85 109.283 178.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.483 ' N ' ' CG ' ' A' ' 10' ' ' TYR . 6.8 t -69.74 -38.57 76.87 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.98 -0.748 . . . . 1.17 108.98 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 12' ' ' LEU . 1.8 mt -61.91 -41.19 97.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.176 -0.676 . . . . 2.09 109.176 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -68.69 -35.11 76.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.837 -0.539 . . . . 1.95 109.896 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -36.05 66.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.657 -0.652 . . . . 3.49 109.895 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -69.46 -46.41 66.75 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.847 -0.797 . . . . 2.48 108.847 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mt -64.49 -35.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 109.209 -0.663 . . . . 1.5 109.209 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.54 -44.38 90.98 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.853 -0.529 . . . . 1.74 109.999 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 -52.91 -49.53 65.76 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.641 -0.662 . . . . 4.07 110.153 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.17 -45.45 49.27 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.263 -1.535 . . . . 0.89 109.263 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.0 tp -57.36 -44.29 84.22 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.663 -0.904 . . . . 1.62 110.258 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.25 81.19 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.761 -0.587 . . . . 2.8 110.413 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -39.53 90.83 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.568 -0.707 . . . . 2.21 110.491 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 20' ' ' LEU . 40.9 mt -60.65 -45.96 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.52 -0.737 . . . . 2.02 109.857 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.8 t -76.76 -32.42 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.683 -0.636 . . . . 1.69 109.759 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.21 -33.19 71.39 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.654 -0.654 . . . . 2.07 110.294 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.78 -46.87 4.4 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.958 -1.257 . . . . 1.75 109.958 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.45 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.1 OUTLIER -127.83 152.27 48.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.424 -1.045 . . . . 5.71 110.677 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 27' ' ' TRP . . . . . . . . 0 N--CA 1.502 2.127 0 CA-C-O 118.769 -0.634 . . . . 4.75 110.738 179.866 . . . . . . . . 1 1 . 1 stop_ save_